FDA hands drugmaker, diagnostics firm warning letters for GMP violations

Regulatory NewsRegulatory NewsDiagnostics/IVDsPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters